共 50 条
- [21] The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cellsBLOOD, 2019, 133 (17) : 1876 - 1887Hirayama, Alexandre V.Gauthier, JordanHay, Kevin A.Voutsinas, Jenna M.Wu, QianGooley, TedLi, DanielCherian, SindhuChen, XueyanPender, Barbara S.Hawkins, Reed M.Vakil, AeshaSteinmetz, Rachel N.Acharya, Utkarsh H.Cassaday, Ryan D.Chapuis, Aude G.Dhawale, Tejaswini M.Hendrie, Paul C.Kiem, Hans-PeterLynch, Ryan C.Ramos, JorgeShadman, MazyarTill, Brian G.Riddell, Stanley R.Maloney, David G.Turtle, Cameron J.
- [22] Efficacy and safety of CAR19/22 T-cell "cocktail" therapy in patients with refractory/relapsed B-cell non-Hodgkin lymphoma.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Huang, LiangWang, NaLi, ChunruiXiao, YiCao, YangXiao, MinZhang, YichengZhang, TongcunZhou, Jianfeng
- [23] CD19 CAR T Cell Product Exhibits High Remission Rate in Adult Relapsed and/or Refractory B-Cell Non-Hodgkin LymphomaBLOOD, 2018, 132Ying, ZhitaoWang, WenWang, XiaopeiZheng, WenLin, NingjingTu, MeifengXie, YanPing, LingyanZhang, ChenLiu, WeipingDeng, LijuanHao, MingYang, SuZhou, YanLi, JamesSong, YuqinZhu, Jun
- [24] CD19 or CD20 CAR T Cell Therapy Demonstrates Durable Antitumor Efficacy in Patients with Central Nervous System LymphomaHUMAN GENE THERAPY, 2022, 33 (5-6) : 318 - 329Liu, RuiCheng, QianKang, LiqingWang, ErhuaLi, YingZhang, JianXiao, HanZhang, YiChu, LingChen, XinZhang, ChangTan, JingwenXu, NanLi, MinghaoYu, LeiLi, Xin
- [25] Humanized CD19 CAR-T Cell Combined with Multiple Combination Treatments in Relapsed/Refractory B-Cell Non-Hodgkin LymphomaBLOOD, 2019, 134Wang, JiaYuan, Ji-junMu, JuanLi, QingMou, NanYang, Zhen-xingLi, WeiLi, LanfangZhao, PeiqiWang, XianhuoPu, YediZhang, HuilaiDeng, Qi
- [26] IMPACT OF INTESTINAL MICROBIOTA IN PATIENTS WITH NON-HODGKIN LYMPHOMA ON THE RESPONSE TO CAR-T CD19 THERAPYHAEMATOLOGICA, 2021, 106 (10) : 63 - 63Roberto, Garcia-VicenteAlba, Rodriguez-GarciaRuben, Gomez-GordoAdriana, Ortega-HernandezSandra, SerranoJavier, ModregoAlejandra, LeivasAntonio, ValeriSanchez-Pina, Jose M.Liz, Paciello MariaDulcenombre, Gomez-GarreJoaquin, Martinez-LopezMaria, Linares
- [27] Safety and efficacy of a novel anti-CD20/CD19 bispecific CAR T-cell therapy (C-CAR039) in relapsed or refractory (r/r) B-cell non-Hodgkin lymphoma (B-NHL).JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Liang, AibinZhou, LiliLi, PingYu, WenjuanYang, MinXu, YangyangYe, ShiguangZhu, JudyHuang, JiaqiZhang, YanLi, LanfangZhao, JingLi, JingZheng, ChengxiaoZhu, KevinLan, LipingZhang, HuilaiZhou, DaobinYao, YihongJin, Jie
- [28] Retrospective Study of CD20 Expression Loss in Relapsed or Refractory B-Cell Non-Hodgkin LymphomaJOURNAL OF HEMATOLOGY, 2024, 13 (06) : 268 - 277Marshalek, Joseph P.Qing, XinDragan, MarcinTomassetti, Sarah
- [29] Postinfusion PD-1+CD8+CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphomaBLOOD ADVANCES, 2024, 8 (12) : 3140 - 3153Denlinger, NathanSong, No-JoonZhang, XiaoliJeon, HyeongseonPeterson, ChelseaWang, YiReynolds, KelsiBolz, Robert M.Miao, JessicaSong, ChunhuaWu, DayongChan, Wing KeungBezerra, EvandroEpperla, NarendranathVoorhees, Timothy J.Brammer, JonathanKittai, Adam S.Bond, David A.Sawalha, YazeedSigmund, AudreyReneau, John C.Rubinstein, Mark P.Hanel, WalterChristian, BethBaiocchi, Robert A.Maddocks, KamiAlinari, LapoVasu, Sumithirade Lima, MarcosChung, DongjunJaglowski, SamanthaLi, ZihaiHuang, XiaopeiYang, Yiping
- [30] Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in BrazilBONE MARROW TRANSPLANTATION, 2024, 59 (07) : 1040 - 1042Donadel, Camila D.De Santis, Gil C.Goncalves, Thiago E.Pires, Bruno G.Palma, Leonardo C.Gava, FlaviaGuerino-Cunha, Renato LuizFaria, Joana T. B.Silva, Gabriela V. A.Darrigo-Junior, Luiz GuilhermeFatobene, GiancarloRocha, VandersonCovas, Dimas T.Calado, Rodrigo T.Cle, Diego, V